The story of how Meisys, a pharmacovigilance service provider supporting 22 pharmaceutical clients, streamlined literature monitoring with DrugCard.
Client:
Location:
Spain
Managing a Complex PV Portfolio
Given its broad and diverse portfolio, Meisys consequently faced several operational challenges:
- Managing multi-sponsor pharmacovigilance obligations – each with different expectations and timelines.
- Reviewing over 10,000 literature articles manually.
- Identifying and classifying safety signals across diverse therapeutic areas.
- Ensuring consistent quality control across diverse projects.
Scaling Pharmacovigilance Efficiently with DrugCard
To tackle these challenges, Meisys implemented DrugCard, using its powerful pharmacovigilance automation tools to:
- Rapidly screen and categorise 10,924 articles from both local and global literature sources.
- Identify 842 articles containing safety information and 292 articles with safety cases.
- Significantly speed up the review process, cutting the time per article to approximately one minute.
From Hours of Work to Minutes Per Article
With DrugCard, Meisys achieved measurable improvements in efficiency, compliance, and scalability:
- Time Savings – Over 4,300 hours were saved reviewing 10,924 articles, cutting the time per article from ~24 minutes to just a few.
- Scalability – Only five users successfully managed 22 pharmacovigilance projects, showing how easily the process could scale.
- Regulatory Readiness – Improved ICSR tracking, quality control, and client-specific filtering made the team fully prepared for audits and inspections.
Ready to Achieve Similar Results?
Stop risking compliance and wasting valuable team hours. Discover how DrugCard can streamline your literature monitoring, expedite the detection of safety signals, and provide your team with complete peace of mind.
Take the next step and experience a personalised demo tailored just for you!
